Biotech startups in Lausanne, Switzerland
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Adaptyv Biosystems | Lausanne | Series A | $40.0M | 2026-08-25 |
| Alithea Genomics | Lausanne | Seed | $3.8M | 2026-03-04 |
| Leman Biotech | Lausanne | Series A | $28.8M | 2026-01-26 |
| Genknowme | Lausanne | Pre-seed | $630K | 2025-12-18 |
| Comphya | Lausanne | Series A | $4.0M | 2025-07-08 |
| Lunaphore | Lausanne | Series D | $32.7M | 2023-03-23 |
| Asceneuron | Lausanne | Series C | $100.0M | 2024-07-16 |
| Hemostod | Lausanne | Seed | $5.4M | 2025-10-01 |
8 rows of the CSV in 5 of its 18 columns.
- The 29 biotech startups in Lausanne, Switzerland have raised $298.5M in total.
- 5 of them closed their most recent round in the last 12 months, $73.7M combined.
- The largest of those rounds is Adaptyv Biosystems' $40.0M Series A, dated August 2026.
- Foundation for Innovation and Technology (FIT) is an investor in 9 of them, more than any other fund.
- Health care is the most common other sector, with 24 companies (83%).
- 24% were founded in 2020 or later; the median founding year is 2016.
- The most common team size is 1 to 10 employees (56% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
13 of 29| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Adaptyv Biosystems | Adaptyv Biosystems develops protein engineering tools using cell-free synthetic biology and nanofluidics technology. | Artificial intelligence | Series A | $40.0M | 2026-08-25 | $50.9M | Y Combinator, Venture Kick, Acequia Capital (AceCap) +2 | 11 to 50 | 2020 |
| Alithea Genomics | Alithea Genomics develops molecular biology tools and sequencing solutions for large-scale gene expression analysis. | Biotech | Seed | $3.8M | 2026-03-04 | $9.9M | Foundation for Innovation and Technology (FIT), TechU Ventures, Eurostars +1 | 11 to 50 | 2020 |
| Leman Biotech | Leman Biotech develops cancer immunotherapies as a biotech company. | Biotech | Series A | $28.8M | 2026-01-26 | $46.8M | Tiantu Capital, Fuho Capital | 11 to 50 | 2021 |
| Genknowme | Genknowme is a precision health company advancing epigenetics to support personalized and preventive care. | Biotech | Pre-seed | $630K | 2025-12-18 | $947K | Venture Kick, Foundation for Innovation and Technology (FIT) | 1 to 10 | 2019 |
| Hemostod | HemostOD manufactures platelets on demand from engineered stem cells. | Biotech | Seed | $5.4M | 2025-10-01 | $7.8M | Foundation for Innovation and Technology (FIT) | 11 to 50 | 2020 |
| Comphya | Comphya develops an active implantable medical device to restore erectile function in patients who do not respond to oral drugs. | Biotech | Series A | $4.0M | 2025-07-08 | $14.2M | Venture Kick, Verve Ventures, Nest Collective Foundation | 1 to 10 | 2017 |
| Regenosca | Regenosca develops biomaterials that serve as alternatives to autologous tissue substitutes for soft tissue repair. | Biotech | Pre-seed | $1.1M | 2024-07-22 | $1.4M | MassChallenge, Venture Kick, Foundation for Innovation and Technology (FIT) +1 | 1 to 10 | 2019 |
| Asceneuron | Asceneuron develops therapeutics for orphan tauopathies and Alzheimer's disease. | Biotech | Series C | $100.0M | 2024-07-16 | OrbiMed, Novo Holdings, EQT Life Sciences +1 | 1 to 10 | 2012 | |
| Lunaphore | Lunaphore is a life sciences company that creates technologies enabling spatial biology in all laboratories. | Biotech | Series D | $32.7M | 2023-03-23 | Venture Kick, VentureOut, redalpine | 11 to 50 | 2014 | |
| Metaphysiks | Metaphysiks combines neuroscience and robotics to create multisensory immersive experiences. | Biotech | Seed | $2.0M | 2022-06-24 | The New Frontiers (TNF) | 1 to 10 | 2016 | |
| Embion Technologies | Embion Technologies offers industrial biomass processing technology for nutrition, pharma, and cosmetics applications. | Biotech | Series A | $4.9M | 2021-12-08 | Venture Kick, Foundation for Innovation and Technology (FIT), Swiss Economic Award | 1 to 10 | 2016 | |
| Saphetor | Saphetor is a company that develops personalised medicine. | Biotech | Series A | $4.2M | 2020-03-27 | $6.6M | Foundation for Innovation and Technology (FIT), GoBeyond, Alpana Ventures +1 | 51 to 100 | 2014 |
| Pryv | Pryv manages personal data and privacy for its clients. | Biotech | Seed | $1.4M | 2019-03-01 | $4.7M | Foundation for Innovation and Technology (FIT) | 1 to 10 | 2012 |
Table 1. Biotech startups in Lausanne, Switzerland: the 13 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 29.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Adaptyv Biosystems | Adaptyv Biosystems develops protein engineering tools using cell-free synthetic biology and nanofluidics technology. | Artificial intelligence | Series A | $40.0M | 2026-08-25 | $50.9M | Y Combinator, Venture Kick, Acequia Capital (AceCap) +2 | 11 to 50 | 2020 |
| 2 | Leman Biotech | Leman Biotech develops cancer immunotherapies as a biotech company. | Biotech | Series A | $28.8M | 2026-01-26 | $46.8M | Tiantu Capital, Fuho Capital | 11 to 50 | 2021 |
| 3 | Alithea Genomics | Alithea Genomics develops molecular biology tools and sequencing solutions for large-scale gene expression analysis. | Biotech | Seed | $3.8M | 2026-03-04 | $9.9M | Foundation for Innovation and Technology (FIT), TechU Ventures, Eurostars +1 | 11 to 50 | 2020 |
| 4 | Genknowme | Genknowme is a precision health company advancing epigenetics to support personalized and preventive care. | Biotech | Pre-seed | $630K | 2025-12-18 | $947K | Venture Kick, Foundation for Innovation and Technology (FIT) | 1 to 10 | 2019 |
Table 2. Biotech startups in Lausanne, Switzerland: the 4 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Foundation for Innovation and Technology (FIT) | Entrepreneurship program | Lausanne, Switzerland | 9 | 31% | 3 | Adaptyv Biosystems, Alithea Genomics, Genknowme |
| 2 | Venture Kick | Startup incubator | Schlieren, Switzerland | 7 | 24% | 2 | Adaptyv Biosystems, Genknowme |
| 3 | Y Combinator | Startup accelerator | Mountain View, United States | 1 | 3% | 1 | Adaptyv Biosystems |
| 4 | Founderful | Venture capital firm | Zürich, Switzerland | 1 | 3% | 1 | Adaptyv Biosystems |
| 5 | Acequia Capital (AceCap) | Venture capital firm | Seattle, United States | 1 | 3% | 1 | Adaptyv Biosystems |
| 6 | Novalis Biotechnology Incubation | Startup incubator | Ghent, Belgium | 1 | 3% | 1 | Alithea Genomics |
| 7 | Eurostars | Government investment office | Brussels, Belgium | 1 | 3% | 1 | Alithea Genomics |
| 8 | TechU Ventures | Venture capital firm | New York, United States | 1 | 3% | 1 | Alithea Genomics |
| 9 | Tiantu Capital | Venture capital firm | Shenzhen, China | 1 | 3% | 1 | Leman Biotech |
| 10 | Fuho Capital | Venture capital firm | Haidian, China | 1 | 3% | 1 | Leman Biotech |
| 11 | Nest Collective Foundation | Pension fund | Zürich, Switzerland | 1 | 3% | ||
| 12 | Verve Ventures | Venture capital firm | Zug, Switzerland | 1 | 3% | ||
| 13 | VentureOut | Startup accelerator | New York, United States | 1 | 3% | ||
| 14 | redalpine | Venture capital firm | Zürich, Switzerland | 1 | 3% | ||
| 15 | Novo Holdings | Corporate venture arm | Hellerup, Denmark | 1 | 3% |
Table 3. Biotech startups in Lausanne, Switzerland: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 24 | 83% | $236.8M |
| Software | 4 | 14% | $55.6M |
| Hardware | 3 | 10% | $1.3M |
| Artificial intelligence | 2 | 7% | $50.9M |
| Commerce | 1 | 3% | $4.7M |
| Cybersecurity | 1 | 3% | $4.7M |
Table 4. Biotech startups in Lausanne, Switzerland by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Pre-seed | 4 | 14% | $630K |
| Seed | 10 | 34% | $2.1M |
| Series A | 10 | 34% | $4.9M |
| Series B | 3 | 10% | $19.5M |
| Series C | 1 | 3% | $100.0M |
| Series D+ | 1 | 3% | $32.7M |
Table 5. Biotech startups in Lausanne, Switzerland by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| August 2026 | 1 | 20% | $40.0M |
| April 2026 | 1 | 20% | $500K |
| March 2026 | 1 | 20% | $3.8M |
| January 2026 | 1 | 20% | $28.8M |
| December 2025 | 1 | 20% | $630K |
Table 6. Biotech startups in Lausanne, Switzerland: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 4 | 14% | $73.1M |
| 2025 | 6 | 21% | $81.0M |
| 2024 | 3 | 10% | $106.4M |
| 2023 | 1 | 3% | $32.7M |
| 2022 | 2 | 7% | $4.1M |
| 2021 | 2 | 7% | $7.6M |
Table 7. Biotech startups in Lausanne, Switzerland by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2020 to 2022 | 7 | 24% |
| 2015 to 2019 | 11 | 38% |
| 2010 to 2014 | 6 | 21% |
| Before 2010 | 5 | 17% |
Table 8. Biotech startups in Lausanne, Switzerland by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 15 | 56% |
| 11 to 50 | 9 | 33% |
| 51 to 100 | 3 | 11% |
Table 9. Biotech startups in Lausanne, Switzerland by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in Lausanne, Switzerland. On 16 November 2026 that is 29 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 13 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 29 rows: 2 have no round amount, 0 no city and 6 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Lausanne, Switzerland are on the list?
- 29, in the file dated 16 November 2026. 5 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 29 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.